Behavioral	behavioral	O	O
effects	effects	O	O
of	of	O	O
diazepam	diazepam	S_chemicals	O
and	and	O	O
propranolol	propranolol	S_chemicals	O
in	in	O	O
patients	patients	O	O
with	with	O	O
panic	panic	O	O
disorder	disorder	O	O
and	and	O	O
agoraphobia	agoraphobia	O	O
.	.	O	O

The	the	O	O
effects	effects	O	O
of	of	O	O
oral	oral	O	O
doses	doses	O	O
of	of	O	O
diazepam	diazepam	S_chemicals	O
(	(	O	O
single	single	O	O
dose	dose	O	O
of	of	O	O
10	10	O	O
mg	mg	O	O
and	and	O	O
a	a	O	O
median	median	O	O
dose	dose	O	O
of	of	O	O
30	30	O	O
mg/day	mg/day	O	O
for	for	O	O
2	2	O	O
weeks	weeks	O	O
)	)	O	O
and	and	O	O
propranolol	propranolol	S_chemicals	O
(	(	O	O
single	single	O	O
dose	dose	O	O
of	of	O	O
80	80	O	O
mg	mg	O	O
and	and	O	O
a	a	O	O
median	median	O	O
dose	dose	O	O
of	of	O	O
240	240	O	O
mg/day	mg/day	O	O
for	for	O	O
2	2	O	O
weeks	weeks	O	O
)	)	O	O
on	on	O	O
psychological	psychological	O	O
performance	performance	O	O
of	of	O	O
patients	patients	O	O
with	with	O	O
panic	panic	O	O
disorders	disorders	O	O
and	and	O	O
agoraphobia	agoraphobia	O	O
were	were	O	O
investigated	investigated	O	O
in	in	O	O
a	a	O	O
double-blind	double-blind	O	O
,	,	O	O
randomized	randomized	O	O
and	and	O	O
crossover	crossover	O	O
design	design	O	O
.	.	O	O

Both	both	O	O
drugs	drugs	S_chemicals	O
impaired	impaired	O	O
immediate	immediate	O	O
free	free	O	O
recall	recall	O	O
but	but	O	O
the	the	O	O
decrease	decrease	O	O
was	was	O	O
greater	greater	O	O
for	for	O	O
diazepam	diazepam	S_chemicals	O
than	than	O	O
propranolol	propranolol	S_chemicals	O
.	.	O	O

Delayed	delayed	O	O
free	free	O	O
recall	recall	O	O
was	was	O	O
also	also	O	O
impaired	impaired	O	O
but	but	O	O
the	the	O	O
two	two	O	O
drugs	drugs	S_chemicals	O
did	did	O	O
not	not	O	O
differ	differ	O	O
.	.	O	O

Patients	patients	O	O
tapped	tapped	O	O
faster	faster	O	O
after	after	O	O
propranolol	propranolol	S_chemicals	O
than	than	O	O
diazepam	diazepam	S_chemicals	O
and	and	O	O
they	they	O	O
were	were	O	O
more	more	O	O
sedated	sedated	O	O
after	after	O	O
diazepam	diazepam	S_chemicals	O
than	than	O	O
propranolol	propranolol	S_chemicals	O
.	.	O	O

After	after	O	O
2	2	O	O
weeks	weeks	O	O
of	of	O	O
treatment	treatment	O	O
,	,	O	O
patients	patients	O	O
tested	tested	O	O
5	5	O	O
-	-	O	O
8	8	O	O
h	h	O	O
after	after	O	O
the	the	O	O
last	last	O	O
dose	dose	O	O
of	of	O	O
medication	medication	O	O
did	did	O	O
not	not	O	O
show	show	O	O
any	any	O	O
decrement	decrement	O	O
of	of	O	O
performance	performance	O	O
.	.	O	O

These	these	O	O
results	results	O	O
are	are	O	O
similar	similar	O	O
to	to	O	O
those	those	O	O
previously	previously	O	O
found	found	O	O
in	in	O	O
healthy	healthy	O	O
subjects	subjects	O	O
.	.	O	O

Accumulation	accumulation	O	O
of	of	O	O
drugs	drugs	S_chemicals	O
was	was	O	O
not	not	O	O
reflected	reflected	O	O
in	in	O	O
prolonged	prolonged	O	O
behavioral	behavioral	O	O
impairment	impairment	O	O
.	.	O	O

